DynaGen (US) gets clearance for three tuberculosis (TB) tests:
This article was originally published in Clinica
Executive Summary
DynaGen (US) has received 510(k) premarket clearance from the FDA for three tuberculosis tests, which will allow early mycobacteria confirmation. The MycoAKT latex identification tests can identify isolates of Mycobacterium tuberculosis complex, M avium complex and M kansasii.